• Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.

  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
中文
logo mimetas

Human Tissue Models for Better Therapies

一个平台胜任各种组织培养

OrganoPlate®平台是一款功能极其丰富且可达到高通量的器官芯片，能够助力研究人员研发具有突破性的人体组织模型。

Drug Discovery

Our phenotypic modeling
technology helps you realize
therapeutic breakthroughs
and reduce costs.

More about discovery
Our model pipeline

Preclinical Research

Human organ models
supporting ADME and safety
with enhanced translatability,
while minimizing reliance
on animal models.

More about ADME/tox

CAR T-Cell Assay Services

渗透性
渗出
转运
胞吞转运

Oncology Whitepaper

侵袭
血管生成
免疫迁移
转移

New Publication

体外移植
灌注血管
肿瘤
类器官

人类组织和疾病模型专家

Unveil

Science Together

Select the right collaboration mode for drug discovery, prioritization and optimization, or compound analysis, all based on our state-of-the-art modelling technologies.

About MIMETAS

Trusted

by the Best

Our success is built on satisfied, returning customers. The trust of leading global pharmaceutical and biotech companies in our capabilities speaks volumes about the quality and value we offer.

Explore Our Technology

A leader in human

relevance and scale

Our organ-on-a-chip technology recreates physiologically relevant environments on the largest scale possible.

See Latest Updates

持续创新

What customers say
'
Our exciting collaboration enables our research and early development group to apply state-of-the-art organ-on-a-chip technology in the modeling of IBD and HBV. These models have the potential to improve our understanding of disease biology and transform
The 'I' in MIMETAS
'
Tackling challenges together.
What customers say
'
"The OrganoReady Colon Caco-2, combined with the OrganoTEER, have become our gold standard in vitro model for the screening of intestinal barrier disruptors at SIAF. "
What customers say
'
The OrganoPlate Caco-2 model is for us, at Merck, the most suitable platform offering at the same time scalability, speed, robustness, ease of handling, with low compound needs.
The 'I' in MIMETAS
Chiwan Chiang
Marketing Specialist
'
A day without
laughter is a day wasted.
Read more
What customers say
'
Mimetas' tumor infiltration platform demonstrated a therapeutic effect of our compound on immune cell recruitment: we’re very excited by these proof of concept data
The 'I' in MIMETAS
Jos Joore
CEO
'
We want to
empower research on complex tissue biology.
Read more
What customers say
'
Often you have to compromise it’s either the throughput or it’s the complexity of the model. Getting both in the same platform… no other platform can do that!
The 'I' in MIMETAS
Nienke Wevers
Senior Scientist
'
Nothing ventured, nothing gained.
Read more
What customers say
'
We were able to measure cell barrier permeabilities in a lung-on-a-chip model demonstrating superior sensitivity and translatability than any other lung cell model we tried before. It was also very easy to scale up our data generation workflow.
The 'I' in MIMETAS
Henriëtte Lanz
Director of Model Development
'
It should be
mandatory to
socialize with colleagues.
Read more
What customers say
'
Organoplates opened avenues that were before considered unreachable
The 'I' in MIMETAS
Bas Trietsch
Chief Technology Officer
'
We try to help
each other
as a team.
Read more
The 'I' in MIMETAS
Jacquelien Ten Dam
Chief Financial Officer
'
It always seems impossible until it’s done.
Read more
The 'I' in MIMETAS
Paul Vulto
CEO
'
Leveraging who you are, is the key to making a difference!
Read more
The 'I' in MIMETAS
Linda Gijzen
Scientific Project Lead
'
Tackling challenges together.
Read more
The 'I' in MIMETAS
Tina Thakkar
Associate Director of Sales
'
It is not really
work if you are
having fun.
Read more
The 'I' in MIMETAS
Liis Rannamäe
Laboratory Technician
'
Can be summarized in three words - engaging, playful, and innovative.
Read more
The 'I' in MIMETAS
Mieke Doornbos
Vice President Sales & Marketing
'
Celebrate
good times.
Read more
The 'I' in MIMETAS
Frederik Schavemaker
Product Design Engineer
'
Pioneering, bringing the best solutions
for scientific
discovery.
Read more
The 'I' in Mimetas
Remko van Vught
Vice President Business Development
'
Making
a difference
together.
Read more
The 'I' in MIMETAS
Lenie van den Broek
Director Biology Discovery
'
Dynamic and innovative - each day holds a surprise.
Read more
The 'I' in Mimetas
Arnaud Nicolas
Associate Director TechCore
'
Own your flaws.
Read more
Latest Whitepaper
'
Closing the Translational Gap in Cancer Drug Discovery with Comprehensive Tumor Models
Scientist
From a top pharma
New Webinar
'
Phenotypic Disease Modeling for Immuno-Oncology: Putting Targets into Patient Context

 

 



By MIMETAS and Molecular Devices
Register here

Press Release
'
MIMETAS and Astellas Enter into Strategic Partnership on Immuno-oncology
Scientist
From a top pharma
News Article
'
First Large-scale Phenotypic Screen Using Organ-on-a-Chip

 

 



By MIMETAS and Molecular Devices
Register here

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all